Irs1 Phenotype Annotations

Mammalian Phenotype Ontology Annotations
Query Results - Summary

Symbol
Name
ID

Irs1
insulin receptor substrate 1
MGI:99454

67 phenotypes from 11 alleles in 13 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Irs1^em1(IMPC)H/Irs1⁺ C57BL/6NTac-Irs1^em1(IMPC)H/H	increased freezing behavior	J:211773
Irs1^em1(IMPC)H/Irs1⁺ C57BL/6NTac-Irs1^em1(IMPC)H/H	increased mean platelet volume	J:211773
Irs1^em1(IMPC)H/Irs1^em1(IMPC)H C57BL/6NTac-Irs1^em1(IMPC)H/H	preweaning lethality, complete penetrance	J:211773
Irs1^m1Btlr/Irs1^m1Btlr C57BL/6J-Irs1^m1Btlr	decreased body weight	J:267531
Irs1^m1Btlr/Irs1^m1Btlr C57BL/6J-Irs1^m1Btlr	increased circulating insulin level	J:267531
Irs1^m2Btlr/Irs1^m2Btlr C57BL/6J-Irs1^m2Btlr	decreased body weight	J:267532
Irs1^mpc178H/Irs1^mpc178H involves: BALB/c * C3H/HeH * C57BL/6J	decreased bone mineral density	J:234901
	postnatal growth retardation	J:234901
Irs1^Sml/Irs1⁺ C3.Cg-Irs1^Sml H2^b/GrsrJ	abnormal femur morphology	J:163661
	decreased body weight	J:163661
	decreased bone mineral density	J:163661
	decreased long bone epiphyseal plate size	J:163661
	decreased total body fat amount	J:163661
	increased circulating insulin level	J:163661
	short femur	J:163661
Irs1^Sml/Irs1^Sml C3.Cg-Irs1^Sml H2^b/GrsrJ	abnormal bone mineralization	J:163661
	abnormal bone structure	J:163661
	abnormal femur morphology	J:163661
	abnormal tail morphology	J:163661
	decreased body size	J:163661
	decreased body weight	J:163661
	decreased bone mineral density	J:163661
	decreased circulating glucose level	J:163661
	decreased long bone epiphyseal plate size	J:163661
	decreased osteoblast proliferation	J:163661
	decreased percent body fat/body weight	J:163661
	decreased trabecular bone thickness	J:163661
	impaired glucose tolerance	J:163661
	impaired osteoblast differentiation	J:163661
	increased circulating insulin level	J:163661
	increased or absent threshold for auditory brainstem response	J:163661
	increased osteoblast cell number	J:163661
	increased osteoclast cell number	J:163661
	insulin resistance	J:163661
	proportional dwarf	J:163661
	short femur	J:163661
	short tail	J:163661
	thin tail	J:163661
Irs1^smla/Irs1^smla involves: 129S1/SvImJ * 129S2/SvPas * C57BL/6	normal mortality/aging	J:164568
Irs1^smla/Irs1^smla involves: 129S2/SvPas * C57BL/6J	decreased body size	J:164568
	postnatal lethality	J:164568
	premature death	J:164568
Irs1^tm1Jos/Irs1^tm1Jos involves: 129S2/SvPas * C57BL/6	decreased birth weight	J:21374
	decreased body size	J:21374
	decreased body weight	J:21374
	impaired glucose tolerance	J:21374
	increased circulating insulin level	J:21374
	insulin resistance	J:21374
	postnatal growth retardation	J:80976
	normal skeleton phenotype	J:21374
	normal vision/eye phenotype	J:98107
Irs1^tm1Mfw/Irs1^tm1Mfw Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA	impaired glucose tolerance	J:137845
Irs1^tm1Tka/Irs1^tm1Tka involves: C57BL/6 * CBA	abnormal bone healing	J:89532
	abnormal cell differentiation	J:68004
	abnormal lipid level	J:47029
	abnormal long bone epiphyseal plate proliferative zone	J:89532
	abnormal long bone hypertrophic chondrocyte zone	J:89532
	abnormal osteoblast physiology	J:61479
	abnormal osteoclast differentiation	J:61479
	abnormal osteoclast physiology	J:61479
	abnormal trabecular bone morphology	J:61479
	abnormal vascular wound healing	J:99746
	decreased body weight	J:47029
	decreased bone mineral content	J:89532
	decreased bone mineral density	J:61479
	decreased bone mineral density of femur	J:61479
	decreased cell proliferation	J:89532
	decreased chondrocyte number	J:61479
	decreased circulating HDL cholesterol level	J:47029
	decreased compact bone thickness	J:61479
	decreased insulin secretion	J:65485
	decreased long bone epiphyseal plate size	J:61479
	decreased osteoblast cell number	J:61479
	decreased vasodilation	J:99746
	normal homeostasis/metabolism phenotype	J:61479
	hypertension	J:47029
	impaired lipolysis	J:47029
	increased circulating free fatty acids level	J:99746
	increased circulating insulin level	J:61479
	increased circulating triglyceride level	J:47029, J:99746
	increased systemic arterial diastolic blood pressure	J:47029
	increased systemic arterial systolic blood pressure	J:47029, J:99746
	insulin resistance	J:99746
	short femur	J:61479
	short tibia	J:61479
Irs1^tm1Tka/Irs1^tm1Tka Not Specified	abnormal glucose homeostasis	J:21373
	abnormal postnatal growth/weight/body size	J:21373
	decreased body weight	J:21373
	decreased fetal weight	J:21373
	fetal growth retardation	J:21373
	normal homeostasis/metabolism phenotype	J:21373
	increased circulating insulin level	J:21373
	insulin resistance	J:21373
	postnatal growth retardation	J:21373
Irs1^tm2.1Mfw/Irs1⁺ involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N	abnormal pancreatic beta cell morphology	J:156999
	increased circulating insulin level	J:156999
Irs1^tm2.1Mfw/Irs1^tm2.1Mfw involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N	abnormal pancreatic beta cell morphology	J:156999
	decreased body length	J:156999
	decreased body weight	J:156999
	impaired glucose tolerance	J:156999
	increased circulating insulin level	J:156999
	insulin resistance	J:156999
Irs1^tm2Tka/Irs1^tm2Tka Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ involves: 129P2/OlaHsd * C57BL/6 * DBA	normal homeostasis/metabolism phenotype	J:137846
	increased circulating insulin level	J:137846
	insulin resistance	J:137846

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 11/12/2024 MGI 6.24